tirzepatide and aod9604 Exploring the Synergistic Effects of AOD 9604 in Weight Management Tirzepatide | Omega Biologics

The American Diabetes Association's 2024 Standards of Care in Diabetes state that for GLP-1 and dual GIP/GLP-1 agonists, "dose escalation should be individualized based on response and tolerability" [8]

alleviated muscle injury

doi: 10.3389/fnmol.2020.590896

A biweekly injection of a fatty-acylated version of this dual agonist improved body weight, glucose homeostasis and lipid metabolism in DIO mice [91]

GLP-2 is a 33-amino-acid proglucagon-derived peptide, which is expressed in the small intestine, mainly in terminal ileum

And then if you have a BMI of 27 or above and have either pre-diabetes, a prior heart attack, a prior stroke or significant peripheral arterial disease, you will also qualify